Winter CME Series: Emerging Paradigms in the Management of Oncology Patients

The University of Illinois Cancer Center is hosting its second annual Winter CME Series. Join us Jan. 29 for Session 3 of the three-part series. Earn up to three hours of Continuing Medical Education credit per session. The series is accredited by Global Education Group.

The target audience is medical oncologists, hematologists, pathologists, oncology nurses, fellows, residents, advanced practice providers, family practitioners, primary care practitioners, allied health professionals and other providers interested in the care of patients with cancer.

Register at the conference website.

Agenda
1 – 2 p.m.: Registration, exhibits and lunch
2 – 2:05 p.m.: Introduction
2:05 – 3 p.m.: Innovative T-cell engagers and adoptive T-cell therapies in lung cancer, melanoma and soft tissue sarcoma (VK Gadi, University of Illinois Cancer Center and Kai He, Ohio State University Comprehensive Cancer Center)
3 – 3:40 p.m.: Approved and emerging diagnostics for early cancer detection and minimal residual disease in colon and lung cancer (Gayatry Mohapatra, University of Illinois Cancer Center)
3:40 – 4:40 p.m.: Break, exhibits, non-CME ancillary event, afternoon pick me up
4:40 – 5:25 p.m.: Principles of antibody-drug conjugate therapy and current approved indications in lung and ovarian cancer (Rajat Thawani, MBBS-University of Chicago)
5:25 – 6 p.m.: Health Equity – Discuss limitations of current registrational studies as they apply to minority populations and FDA guidance for improving this racial disparity (Ameen Salahudeen, University of Illinois Cancer Center)
6 – 7 p.m.: Exhibits

Series course chair: Matias E Sanchez, Assistant Professor of Medicine, UI Health Division Hematology and Oncology, University of Illinois Cancer Center

Session 3 chair: Ameen Salahudeen, Assistant Professor, Division of Hematology and Oncology, University of Illinois Cancer Center

Faculty presenters:
VK Gadi, Professor and Director of Medical Oncology, UI Health Division of Hematology and Oncology and Deputy Director, University of Illinois Cancer Center

Kai He, Assistant Professor, Ohio State University Comprehensive Cancer Center

Gayatry Mohapatra, Assistant Professor of Pathology, University of Illinois Cancer Center

Ameen Salahudeen, Assistant Professor, University of Illinois Cancer Center

Rajat Thawani, Assistant Professor, University of Chicago

Educational goal: This conference aims to educate practitioners and update their knowledge of advances in diagnostic modalities in oncology.

Learning objectives: After participating in these activities, learners will better understand:
• Limitations of current registrational studies as they apply to minority populations and FDA guidance for improving this racial disparity (health equity)
• Principles of antibody-drug conjugate therapy and current approved indications
• Principles of biological cell engagers and cell therapies and current approved indications
• Currently approved and emerging diagnostics for early cancer detection and minimal residual disease